Study gut immune tissue in HIV cure efforts
Part of Immune system & allergy, Infections clinical trials.
This study looks at how immune tissue in the gut may be involved in curing HIV. You may be asked to have two colonoscopies while on an HIV “cure-related” treatment, so researchers can collect tissue samples to understand what’s happening in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form and agree to follow study steps for the whole study period.
- You’re 18 to 75 years old.
- You have ongoing (chronic) HIV infection confirmed by blood testing, and you’re on a treatment that could be aimed at curing HIV.
- You’re willing and able to have a colonoscopy twice during the study timeframe.
- You should not have known bleeding/clotting problems or abnormal clotting test results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research compares the immune system in the gut lining, spinal fluid, lymph nodes, and blood between people living with HIV and people not living with HIV. Results may help scientists understand how immunity works and how it differs with HIV.
This study looks at why HIV remains in the body even when treatment is working well. You would have a colonoscopy (already scheduled for medical reasons) and allow the research team to take extra tissue samples to study how the virus hides in the gut.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
This study looks at how changing your HIV medication affects the bacteria in your gut. You'll provide two stool samples so researchers can see what changes happen.
This trial compares how HIV “reservoirs,” inflammation, and the gut microbiome change when people switch from daily HIV pills to long-acting injectable treatment. It may help you and your team understand what to expect with the switch and how your body responds.
This trial tests a combination of two experimental drugs designed to 'shock and kill' hidden HIV in your body. It is for people with HIV-1 subtype B who are on successful ART and want to explore a potential step toward a cure.
Hear when a new HIV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.